Decreased Phosphorylation of NMDA Receptor Type 1 at Serine 897 un Brains of Patients with Schizophrenia

Journal of Neuroscience

Volumn 24, Issue 7, 2004, Pages 1561-1564

  Emamian, Effat S ^a,b   Karayiorgou, Maria ^a   Gogos, Joseph A ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Dept of Physiol and Cell Biophys ^*  (United States)

Author keywords

NMDA receptors; NR1; Phosphorylation; Postmortem; Schizophrenia; Serine 897

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NEUROLEPTIC AGENT; RECEPTOR SUBUNIT; SERINE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RECEPTOR DENSITY; REGULATORY MECHANISM; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

ANTIBODY SPECIFICITY; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; FRONTAL LOBE; HUMANS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; REFERENCE VALUES; SCHIZOPHRENIA; SERINE; TUMOR SUPPRESSOR PROTEINS;

EID: 1242319331     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4650-03.2004     Document Type: Article

References (20)

1. Bading H, Greenberg ME (1991) Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science 253:912-914.
2. Birle D, Bottini N, Williams S, Huynh H, deBelle I, Adamson E, Mustelin T (2002) Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation. J Immunol 169:286-291.
3. Gerber DJ, Hall D, Miyakawa T, Demars S, Gogos JA, Karayiorgou M, Tonegawa S (2003) Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci USA 100:8993-8998.
4. Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, Hayden DL, McCarley R, Coyle JT (1999) A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 56:21-27.
5. Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M (1999) Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry 56:29-36.
6. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
7. Kilts CD (2001) The changing roles and targets for animal models of schizophrenia. Biol Psychiatry 50:845-855.
8. Leveque J-C, Macias W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S, Li X-M, Coyle JT, Huganir RL, Heckers S, Konradi C (2000) Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci 20:4011-4020.
9. Maldve RE, Zhang TA, Ferrani-Kile K, Schreiber SS, Lippmann MJ, Snyder GL, Fienberg AA, Leslie SW, Gonzales RA, Morrisett RA (2002) DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens. Nat Neurosci 5:641-648.
10. Meador-Woodruff JH, Healy DJ (2000) Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev 31:288-294.
11. Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H, Caron MG, Tonegawa S (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 100:8987-8992.
12. Rajadhyaksha A, Barczak A, Macias W, Leveque JC, Lewis SE, Konradi C (1999) L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J Neurosci 19:6348-6359.
13. Roche KW, O'Brien RJ, Mammen AL, Bernhardt J, Huganir RL (1996) Characterization of multiple phosphorylation sites on the AMPA receptor GluRI subunit. Neuron 16:1179-1188.
14. Schiffer HH (2002) Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders? Mol Neurobiol 25:191-212.
15. r 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J Neurosci 18:10297-10303.
16. Swope SL, Moss SJ, Raymond LA, Huganir RL (1999) Regulation of ligand-gated ion channels by protein phosphorylation. Adv Second Messenger Phosphoprotein Res 33:49-78.
17. Thaker G, Carpenter Jr WT (2001) Advances in schizophrenia. Nat Med 7:667-671.
18. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT, Huganir RL (1997) Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 272:5157-5166.
19. Torrey F, Webster M, Knable M, Johnston N, Yolken RH (2000) The Stanley Foundation brain collection and neuropathology consortium. Schizophrenia Res 44:151-155.
20. Tsai G, Yang P, Chung LC, Lange N, Coyle JT (1998) D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 44:1081-1089.